|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/30 | (2006.01) |
| A61K 51/1063 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/3046 | (2013.01) | ||
| C07K2317/73 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/732 | (2013.01) | ||
| C12N 5/12 | (2006.01) | ||
| A61K 51/10 | (2006.01) | ||
| C07K2317/734 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 47/6813 | (2017.08) | ||
| C07K 16/18 | (2006.01) | ||
| A61K 47/6821 | (2017.08) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 47/6823 | (2017.08) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 47/6829 | (2017.08) | ||
| A61K 47/68 | (2017.01) | ||
| A61K 47/6863 | (2017.08) | ||
| A61P 35/04 | (2006.01) | ||
| A61K 47/6809 | (2017.08) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Patento numeris | 4112645 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 22154316.8 |
| Europos patento paraiškos padavimo data | 2006-11-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2023-01-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-06-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 05025657 | 2005-11-24 | EP |
| (72) |
SAHIN, Ugur , DE
TÜRECI, Özlem , DE
USENER, Dirk , DE
FRITZ, Stefan , DE
UHEREK, Christoph , DE
BRANDENBURG, Gunda , DE
GEPPERT, Harald-Gerhard , DE
SCHRÖDER, Anja Kristina , DE
THIEL, Philippe , DE
|
| (73) |
Astellas Pharma Inc. ,
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku
Tokyo 103-8411,
JP
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH , Freiligrathstrasse 12, 55131 Mainz, DE |
| (54) | MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER |
| MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER |